ArticleScientific reports2025
RAUM-GANs: a multi-layer GAN-enhanced framework for accurate multiple sclerosis lesion segmentation in MRI.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Longitudinal deep learning-based segmentation of multiple sclerosis lesions in a local clinical cohort.Frontiers in radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by inflammatory brain lesions, making MRI-based lesion segmentation challenging due to noise, missing data, and limited availability of high-quality labeled images. This paper presents RAUM-GANs, a multi-layer deep learning framework designed to address these challenges and enhance segmentation accuracy. The preprocessing stage comprises three layers: (1) noise reduction using a modified Denoising GAN (DGAN-Net), achieving peak signal-to-noise ratio (PSNR) values up to 42.21 dB across varying noise levels; (2) missing data imputation through advanced GAN-based methods, ensuring clinically reliable reconstruction of incomplete MRI scans; and (3) dataset expansion via a Multi-level Identity GAN (MGAN), which incorporates an identity block to prevent mode collapse, an 8-connected pixel constraint to maintain spatial coherence, and a softened discriminator output to mitigate vanishing gradients. For segmentation, a Residual Attention U-Net (RAU-Net) with identity mapping is employed, yielding precise detection and delineation of MS lesions. Extensive evaluation on the MICCAI MSSEG-2 dataset demonstrates that RAUM-GANs outperform four state-of-the-art methods, achieving a Dice score of 96.6%, Fréchet Inception Distance (FID) of 43.13, and Inception Score (IS) of 14.03. The results highlight the framework's ability to generate high-quality synthetic MRI data, improve robustness against noise and incomplete information, and deliver superior lesion segmentation performance. RAUM-GANs provides a comprehensive, scalable solution for MS lesion analysis, with potential applicability to other medical imaging domains where data quality and scarcity remain significant barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.